Basic HTML Version
113
SCIENTIFIC REPORT 2012
Title:
Effect of lacosamide on depressive and anxiety symptoms in patients with
epilepsy.
District Attorney:
Sea Hospital
Principal Investigator:
Gemma Sansa Fayos.
Title:
Swallowing phobia: associated factors, diagnosis and treatment in the Health Center
Mental Infant-Juvenile.
District Attorney:
Own.
Principal Investigator:
Jordi Torralbas Ortega.
Title:
Randomized, double-blind, placebo-controlled study to investigate efficacy and
safety of GSK1605786A in the treatment of patients with active Crohn's disease
from moderate to severe.
District Attorney:
GlaxoSmithKline Research & Development Limited.
Principal Investigator:
Xavier Calvet Calvo
Title:
Randomized, double-blind, parallel-group, placebo-controlled study for
to evaluate the efficacy and clinical safety of NNC0114-0006 in subjects with Crohn's disease
active.
District Attorney:
New Nordisk.
Principal Investigator:
Xavier Calvet Calvo
Title:
Why is patients' sleep disturbed in a semi-critical room?
District Attorney:
Own.
Principal Investigator:
Aida Betriu Semperi.
Title:
Level of stress perceived by patients in an intensive care unit.
District Attorney:
Own.
Principal Investigator:
Núria Geriqué Caralt.
Title:
Phase II, randomized, double-blind, placebo-controlled, group-based clinical trial
to evaluate the efficacy and follow-up of E-52832 (400 mg) orally in patients
with Postherpetic Neuralgia (PNH).
District Attorney:
Esteve Laboratories.
Principal Investigator:
Jenaro Manero Rey